RxDoctor Payments Data

Kenneth Bannon

Physician Assistant · Carbondale, PANPI 1821055047

Payments from drug & device makers

$8,666in general payments, 2019–2025

Across 355 payments — averaging $24.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • QOL Medical, LLC$968
  • Johnson & Johnson$916
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$602
  • GSK$547
  • Ardelyx, Inc.$438
  • plus $3K from 36 others

What the payments were for

  • Food & beverage$8,659100%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,666 in reported general payments places this provider in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$106,981
Medicare patients
686
Services billed
1,212

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
StelaraUstekinumab19$570,907
CreonLipase/Protease/Amylase63$248,487
SucraidSacrosidase11$118,895
LinzessLinaclotide20$27,766
Mesalamine29$15,785
SutabSod Sulf/Pot Chloride/Mag Sulf84$13,334
ClenpiqSod Picosulf/Mag Ox/Citric Ac71$12,015
Dexlansoprazole DrDexlansoprazole21$8,107
Omeprazole285$6,511
Pantoprazole Sodium198$4,304
Colesevelam Hcl32$3,140
PlenvuPeg3350/Sod Sul/Nacl/Kcl/Asb/C19$2,635
Budesonide EcBudesonide14$2,480
Famotidine153$2,443
Ursodiol12$2,129

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonStelara$916$570,90719 claims
AbbVieCreon, Linzess$1,873$276,25383 claims
QOL Medical, LLCSucraid$968$118,89511 claims
Braintree Laboratories, Inc.Sutab$14$13,33484 claims
Ferring Pharmaceuticals Inc.Clenpiq$46$12,01571 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCPlenvu$602$2,63519 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Carbondale

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →